Download MendeleyAcylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.
Cole, D.C., Stock, J.R., Chopra, R., Cowling, R., Ellingboe, J.W., Fan, K.Y., Harrison, B.L., Hu, Y., Jacobsen, S., Jennings, L.D., Jin, G., Lohse, P.A., Malamas, M.S., Manas, E.S., Moore, W.J., O'Donnell, M.M., Olland, A.M., Robichaud, A.J., Svenson, K., Wu, J., Wagner, E., Bard, J.(2008) Bioorg Med Chem Lett 18: 1063-1066
- PubMed: 18162398
- DOI: https://doi.org/10.1016/j.bmcl.2007.12.010
- Primary Citation of Related Structures:
2ZDZ, 2ZE1 - PubMed Abstract:
Proteolytic cleavage of amyloid precursor protein by beta-secretase (BACE-1) and gamma-secretase leads to formation of beta-amyloid (A beta) a key component of amyloid plaques, which are considered the hallmark of Alzheimer's disease. Small molecule inhibitors of BACE-1 may reduce levels of A beta and thus have therapeutic potential for treating Alzheimer's disease. We recently reported the identification of a novel small molecule BACE-1 inhibitor N-[2-(2,5-diphenyl-pyrrol-1-yl)-acetyl]guanidine (3.a.1). We report here the initial hit-to-lead optimization of this hit and the SAR around the aryl groups occupying the S(1) and S(2') pockets leading to submicromolar BACE-1 inhibitors.
Organizational Affiliation:
Chemical & Screening Sciences, Wyeth Research, 401 N. Middletown Road, Pearl River, NY 10965, USA. coledc@wyeth.com
